Advertisement
UK markets open in 6 hours
  • NIKKEI 225

    37,322.51
    -757.19 (-1.99%)
     
  • HANG SENG

    16,385.87
    +134.03 (+0.82%)
     
  • CRUDE OIL

    82.60
    -0.13 (-0.16%)
     
  • GOLD FUTURES

    2,392.50
    -5.50 (-0.23%)
     
  • DOW

    37,775.38
    +22.07 (+0.06%)
     
  • Bitcoin GBP

    50,541.44
    +1,045.34 (+2.11%)
     
  • CMC Crypto 200

    1,305.65
    +420.11 (+47.13%)
     
  • NASDAQ Composite

    15,601.50
    -81.87 (-0.52%)
     
  • UK FTSE All Share

    4,290.02
    +17.00 (+0.40%)
     

Is It Time To Consider Buying Molina Healthcare, Inc. (NYSE:MOH)?

Today we're going to take a look at the well-established Molina Healthcare, Inc. (NYSE:MOH). The company's stock saw significant share price movement during recent months on the NYSE, rising to highs of US$348 and falling to the lows of US$282. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether Molina Healthcare's current trading price of US$287 reflective of the actual value of the large-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at Molina Healthcare’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

View our latest analysis for Molina Healthcare

What is Molina Healthcare worth?

The stock seems fairly valued at the moment according to my valuation model. It’s trading around 7.05% above my intrinsic value, which means if you buy Molina Healthcare today, you’d be paying a relatively fair price for it. And if you believe that the stock is really worth $267.78, then there isn’t really any room for the share price grow beyond what it’s currently trading. Furthermore, Molina Healthcare’s low beta implies that the stock is less volatile than the wider market.

Can we expect growth from Molina Healthcare?

earnings-and-revenue-growth
earnings-and-revenue-growth

Future outlook is an important aspect when you’re looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. Molina Healthcare's earnings over the next few years are expected to increase by 59%, indicating a highly optimistic future ahead. This should lead to more robust cash flows, feeding into a higher share value.

What this means for you:

Are you a shareholder? MOH’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the financial strength of the company. Have these factors changed since the last time you looked at the stock? Will you have enough conviction to buy should the price fluctuates below the true value?

ADVERTISEMENT

Are you a potential investor? If you’ve been keeping tabs on MOH, now may not be the most advantageous time to buy, given it is trading around its fair value. However, the optimistic prospect is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

If you want to dive deeper into Molina Healthcare, you'd also look into what risks it is currently facing. For example - Molina Healthcare has 2 warning signs we think you should be aware of.

If you are no longer interested in Molina Healthcare, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.